Diagnosis and management of growth disorders comprises an important area of pediatric practice.
Current procedures in the different stages of the identification, referral, investigation, and treatment of growth disorders in the Gulf Cooperation Council (GCC) countries have been summarized.
Evidence-based procedures, relating specifically to height screening for identification of short stature, auxological criteria for patient referral from primary to secondary pediatric care, and general and endocrine investigations and diagnosis have been discussed and outlined.
The management issues related to key disorders that are licensed for growth hormone (HGH) therapy, namely GH deficiency, Turner syndrome, short stature related to birth size small for gestational age (SGA), and idiopathic short stature are discussed with recommendations described for best practice.
Finally, two key components of short stature management, namely transitional care for the transfer of patients from pediatric to adult endocrinology services and adherence to recommended therapy with HGH
Somatropin
It is used to treat growth failure in children and adults who lack natural growth hormone.Growth hormone (GH) or somatotropin, also known as human growth hormones (HGH or HGH) in its human form, is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals.
It is thus important in human development Somatropin is also used in adults to treat short bowel syndrome, or to prevent severe weight loss related to AIDS Somatropin HGH is also for People who are growing older, have suffered a wound or other injury, want to increase their muscle tone and strength for athletics, or who suffer from HGH deficiency and are now looking for ways to bring their HGH levels up to enjoy the benefits of HGH under control of physician can be One potential method to use synthetic HGH.